Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient? Reply

Autor: Chinot, O.L., Taphoorn, M.J.B., Bais, C., Bourgon, R., Phillips, H.S., Abrey, L.E., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., Cloughesy, T.

Publikováno v: Journal of Clinical Oncology, 34(11), 1282-+. American Society of Clinical Oncology
Chinot, O L, Taphoorn, MJB, Bais, C, Bourgon, R, Phillips, H S, Abrey, L E, Wick, W, Mason, W P, Henriksson, R, Saran, F, Nishikawa, R & Cloughesy, T 2016, ' Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient? Reply ', Journal of Clinical Oncology, vol. 34, no. 11, pp. 1282-+ . https://doi.org/10.1200/JCO.2015.65.2438
Journal of Clinical Oncology, 34(11), 1282

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0068941218185515d55e4509561f4dca
https://research.vumc.nl/en/publications/c7c3690f-354f-4f75-bd40-c8ac5a6d220f

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

8O_PR - TGF-β signalling attenuates tumour response to PD-L1 checkpoint blockade by contributing to retention of T cells in the peritumoural stroma

Autor: Mariathasan, S., Turley, S.J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Edward E, K., III, Koeppen, H., Astarita, J.L., Cubas, R., Jhunjhunwala, S., Yang, Y., Şenbabaoğlu, Y., van der Heijden, M., Loriot, Y., Mellman, I., Chen, D., Hegde, P., Bourgon, R., Powles, T.

Publikováno v: In Annals of Oncology December 2017 28 Supplement 11:xi30-xi30

156PD - Targeted NGS profiling identifies genomic alterations associated with high-risk eBC

Autor: Wilson, T.R. ¹, Udyavar, A.R. ², Chang, C-W. ³, Giltnane, J. ⁴, Spoerke, J.M. ¹, Aimi, J. ¹, Savage, H. ¹, Daemen, A. ², Bourgon, R. ², Lackner, M.R. ¹

Publikováno v: In Annals of Oncology September 2017 28 Supplement 5:v46-v46

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.